Differential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent

Weiping Qin1, Jiangping Pan, William A Bauman

  • 1Center of Excellence for the Medical Consequences of Spinal Cord Injury, James J, Peters VA Medical Center, 130 West Kingsbridge Road, Bronx, New York 10468, USA.

BMC Genomics
|October 26, 2010
PubMed
Abstract

Insights

Nandrolone protects against muscle atrophy, but its effects on gene expression change over time. This study identified specific genes regulated by nandrolone at different time points, revealing mechanisms behind its muscle-preserving actions.

Area of Science:

  • Muscle atrophy research
  • Molecular biology
  • Pharmacology

Background:

  • Anabolic steroids like nandrolone can slow muscle atrophy, but the underlying mechanisms and time-dependent effects remain unclear.
  • Understanding these mechanisms is crucial for developing effective therapeutic strategies for muscle wasting conditions.

Purpose of the Study:

  • To investigate the time-dependent effects of nandrolone on gene expression in denervated muscle.
  • To identify specific genes regulated by nandrolone that contribute to its muscle-protective effects.
  • To elucidate the molecular pathways involved in nandrolone's action on muscle atrophy.

Main Methods:

  • Utilized Affymetrix microarrays to profile gene expression in denervated muscle treated with nandrolone at 7 and 35 days.
  • Compared gene expression profiles between different time points to identify nandrolone-regulated genes and changes in denervated muscle.
  • Analyzed the correlation between mRNA levels and muscle size.

Main Results:

  • Nandrolone differentially regulated 124 genes at 7 days and 122 genes at 35 days, with only 20 common genes.
  • At 35 days, nandrolone reduced FOXO1, REDD2, and RCAN2, while increasing ApoD, correlating with muscle size.
  • Nandrolone also modulated Wnt signaling pathway genes and altered expression of transcriptional coregulators, transcription factors, and kinases.

Conclusions:

  • Gene expression changes induced by nandrolone in denervated muscle are distinct at 7 and 35 days.
  • Regulated genes, including FOXO1 and those in calcineurin, mTOR, and Wnt signaling pathways, may mediate nandrolone's beneficial effects on muscle.
  • Time-dependent alterations in transcription and intracellular signaling genes likely contribute to nandrolone's complex effects on muscle atrophy.